Diabetes Care Devices - Ghana | Statista Market Forecast

In Ghana, the revenue in the Diabetes Care Devices market market is projected to reach US$8.95m in 2024.
It is expected that this revenue will demonstrate an annual growth rate (CAGR 2024-2029) of 12.65%, culminating in a market volume of US$16.23m by 2029.
When compared globally, the highest revenue will be generated the United States, amounting to US$11.71bn in 2024.
In Ghana, the adoption of innovative diabetes care devices is rising, driven by increasing awareness and healthcare initiatives addressing the growing prevalence of diabetes.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Ghana is witnessing considerable growth, fueled by rising diabetes prevalence, increased health awareness, and enhanced access to advanced monitoring technologies, which collectively improve patient management and outcomes.

Customer preferences: Consumers in Ghana are increasingly prioritizing integrated diabetes management solutions that combine technology with personalized care. This shift is influenced by a growing awareness of diabetes risk factors and the importance of proactive health management. Additionally, younger demographics are gravitating towards smart devices that offer real-time data tracking and mobile app connectivity, facilitating better engagement in their health journeys. Cultural emphasis on community support is also driving interest in collaborative health platforms, enhancing the collective approach to diabetes care.

Trends in the market: In Ghana, the Diabetes Care Devices Market is experiencing a surge in demand for integrated diabetes management tools, as consumers prioritize technology-driven solutions alongside personalized care. This trend is propelled by heightened awareness of diabetes risks and the necessity for proactive health management. Younger populations are increasingly adopting smart devices that provide real-time data tracking and mobile app integration, promoting active participation in their health journeys. Furthermore, the cultural focus on community support is fostering interest in collaborative health platforms, which may enhance diabetes care and drive innovation among industry stakeholders.

Local special circumstances: In Ghana, the Diabetes Care Devices Market is uniquely influenced by its diverse geography and vibrant cultural practices. Urban areas are witnessing a rapid adoption of mobile health technologies, driven by improved internet connectivity and a youthful demographic eager for innovative health solutions. Meanwhile, rural regions face challenges in access to healthcare, prompting interest in portable, user-friendly diabetes management devices. Culturally, community-based initiatives are pivotal, fostering collective responsibility in health management and promoting local partnerships to enhance awareness and education around diabetes care.

Underlying macroeconomic factors: The Diabetes Care Devices Market in Ghana is shaped by several macroeconomic factors, including national economic stability, healthcare investment, and global health trends. A growing economy, bolstered by foreign investment and remittances, enhances spending on healthcare and medical devices. Additionally, government initiatives aimed at improving healthcare access and affordability support the adoption of diabetes management technologies. Global trends, such as the rise in diabetes prevalence and a shift towards preventive care, further drive demand for innovative devices. Favorable fiscal policies and international partnerships also play a crucial role in advancing diabetes care solutions across the country.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.